InvestLog
Back to Market返回行情

COSM Cosmos Health Inc.

USHealthcare
$0.2927+12.02%ClosedMarket Cap: $18.2M

As of 2026-07-10 16:00

Why COSM matters now

Cosmos Health Inc. (COSM) is a US stock in Healthcare. The latest InvestLog snapshot shows $0.29 with +12.02% on the session and $18.2M in market capitalization; recent performance reads 1-month -24.64% and YTD -57.25%.

The latest financial table shown here is Q1 2026, with revenue of $17.9M, net income of $-2.8M, and EPS of $-0.06. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -83.9%.

The latest indexable market news headline is "Cosmos Health Launches Subscription Model" from GlobeNewsWire.

Additional event context on this page matters because analyst consensus is available with a median target of $—; recent insider activity includes Terzis Georgios filing P-Purchase. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

—

PEG

—

P/B

0.51

P/S

0.19

EV/EBITDA

-1.81

DCF Value

$-5.35

FCF Yield

-83.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

10.4%

Operating Margin

-25.7%

Net Margin

-30.4%

ROE

-96.5%

ROA

-33.9%

ROIC

-45.7%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$17.9M$-2.8M$-0.06
Q4 2025$19.7M$-10.1M$-0.33
FY 2025$65.3M$-19.1M$-0.63
Q3 2025$17.1M$-5.4M$-0.17

Analyst Ratings

Consensus

—

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

Strong Buy: 0Buy: 0Hold: 0Sell: 0Strong Sell: 0

Trading Activity

Insider Trades

Terzis Georgiosofficer: Chief Financial Officer
Buy2026-06-17
Siokas Grigoriosdirector, 10 percent owner, officer: Chief Executive Officer
Buy2026-06-12
Siokas Grigoriosdirector, 10 percent owner, officer: Chief Executive Officer
Buy2026-06-12
Siokas Grigoriosdirector, 10 percent owner, officer: Chief Executive Officer
Sell2026-06-11
Siokas Grigoriosdirector, 10 percent owner, officer: Chief Executive Officer
Sell2026-06-11

Related Stocks

CASI
CASI Pharmaceuticals, Inc.
$2.3M
CLSD
Clearside Biomedical, Inc.
$2.1M
FEMY
Femasys Inc.
$12.0M
IINN
Inspira Technologies Oxy B.H.N. Ltd.
$45.0M
LSTA
Lisata Therapeutics, Inc.
$31.4M

Latest News

Cosmos Health Launches Subscription ModelGlobeNewsWire · 2026-07-10
Cosmos Health Launches Subscription ModelGlobe News Wire · 2026-07-10
Cosmos Health Expands Share Buyback to 4.14 Million Shares; Continues Open Market RepurchasesGlobeNewsWire · 2026-07-09
Cosmos Health Share Buyback Surpasses 4 Million Shares; Continues Open Market RepurchasesGlobeNewsWire · 2026-07-08
Cosmos Health Share Buyback Expands to 3.87 Million Shares; Continues Open Market RepurchasesGlobeNewsWire · 2026-07-07

Company Info

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

US

Exchange

—

Beta

4.12

Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace. The company actively seeks, obtains, develops, and commercializes solutions designed to improve patients' well-being and health outcomes. Supporting these operations, it maintains distribution centers in both Greece and the United Kingdom, alongside a dedicated warehousing facility. Its clientele includes wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was established in 2009 and has its headquarters in Chicago, Illinois.